[VRDN] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -60.09%
YoY- -166.88%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 72 98 216 1,451 828 372 4,784 -50.27%
PBT -48,542 -68,151 -25,693 -18,460 -8,044 -11,629 -4,661 47.72%
Tax -145 -105 -196 55 27 339 167 -
NP -48,542 -68,046 -25,497 -18,460 -8,044 -11,629 -4,661 47.72%
Tax Rate - - - - - - - -
Total Cost 48,614 68,144 25,713 19,911 8,872 12,001 9,445 31.36%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -67,419.44 -69,434.69 -11,804.17 -1,272.23 -971.50 -3,126.08 -97.43 197.10%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.79 -1.61 -0.98 -2.91 -2.65 -5.65 -2.64 -18.20%
EPS Diluted -0.79 -1.61 -0.98 -2.91 -2.65 -5.65 -2.64 -18.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.